ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stuart L Marcus, MD, PhD
Sponsor GmbH
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Irvine
Irvine, California, United States
- University of California, San Francisco
San Francisco, California, United States
- University of Miami
Miami, Florida, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- the Mount Sinai Medical Center
New York, New York, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2009
- Primary completion
- 30 Sept 2011
- Completion
- 30 Sept 2011
- Last update posted
- 21 Oct 2011
- Registered enrollment
- 6
- Registry id
- NCT00865878
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.